RIPK pathway, as a potential target, for cancer treatment - a review

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

التفاصيل البيبلوغرافية
المؤلف الرئيسي: Jahan, Nusrat
مؤلفون آخرون: Chowdhury, Namara Mariam
التنسيق: أطروحة
اللغة:English
منشور في: Brac University 2024
الموضوعات:
الوصول للمادة أونلاين:http://hdl.handle.net/10361/22051
id 10361-22051
record_format dspace
spelling 10361-220512024-01-02T21:02:39Z RIPK pathway, as a potential target, for cancer treatment - a review Jahan, Nusrat Chowdhury, Namara Mariam School of Pharmacy, Brac University Cancer RIPK Pathway Inhibitors Therapy Anti-cancer drugs Cancer--Treatment This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023. Cataloged from PDF version of thesis. Includes bibliographical references (pages 45-48). Cancer is one of the most feared diseases whose prevalence has been drastically increasing in recent years. Among different types of treatment options, the development of kinase-targeted cancer therapies is currently the most studied target for potential anti-cancer therapies. After G-protein-coupled receptors, protein kinases significantly grab the attraction as a target of developing anti-cancer drugs. Based on current research, this review article outlines receptor-interacting protein kinases specially RIP1 and RIP3 as attractive targets over other kinases in the treatment of numerous types of cancer, especially for their tumorigenesis functions in cancer metastasis. Nusrat Jahan B. Pharmacy 2024-01-02T10:27:12Z 2024-01-02T10:27:12Z 2023 2023-02 Thesis ID 19146057 http://hdl.handle.net/10361/22051 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 48 pages application/pdf Brac University
institution Brac University
collection Institutional Repository
language English
topic Cancer
RIPK
Pathway
Inhibitors
Therapy
Anti-cancer drugs
Cancer--Treatment
spellingShingle Cancer
RIPK
Pathway
Inhibitors
Therapy
Anti-cancer drugs
Cancer--Treatment
Jahan, Nusrat
RIPK pathway, as a potential target, for cancer treatment - a review
description This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
author2 Chowdhury, Namara Mariam
author_facet Chowdhury, Namara Mariam
Jahan, Nusrat
format Thesis
author Jahan, Nusrat
author_sort Jahan, Nusrat
title RIPK pathway, as a potential target, for cancer treatment - a review
title_short RIPK pathway, as a potential target, for cancer treatment - a review
title_full RIPK pathway, as a potential target, for cancer treatment - a review
title_fullStr RIPK pathway, as a potential target, for cancer treatment - a review
title_full_unstemmed RIPK pathway, as a potential target, for cancer treatment - a review
title_sort ripk pathway, as a potential target, for cancer treatment - a review
publisher Brac University
publishDate 2024
url http://hdl.handle.net/10361/22051
work_keys_str_mv AT jahannusrat ripkpathwayasapotentialtargetforcancertreatmentareview
_version_ 1814307295772803072